The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells
Open accessAbstract
Aberrant expression of microRNA-146a (miR-146a) has been reported to be involved in the development and progression of various types of cancers. However, its role in non-small cell lung cancer (NSCLC) has not been elucidated. The aim of this study was to investigate the contribution of miR-146a to various aspects of the malignant phenotype of human NSCLCs. In functional experiments, miR-146a suppressed cell growth, induced cellular apoptosis and inhibited EGFR downstream signaling in five NSCLC cell lines (H358, H1650, H1975, HCC827 and H292). miR-146a also inhibited the migratory capacity of these NSCLC cells. On the other hand, miR-146a enhanced the inhibition of cell proliferation by drugs targeting EGFR, including both TKIs (gefitinib, erlotinib, and afatinib) and a monoclonal antibody (cetuximab). These effects were independent of the EGFR mutation status (wild type, sensitizing mutation or resistance mutation), but were less potent compared to the effects of siRNA targeting of EGFR. Our results suggest that these effects of miR-146a are due to its targeting of EGFR and NF-κB signaling. We also found, in clinical formalin fixed paraffin embedded (FFPE) lung cancer samples, that low expression of miR-146a was correlated with advanced clinical TNM stages and distant metastasis in NSCLC (P<0.05). The patients with high miR-146a expression in their tumors showed longer progression-free survival (25.6 weeks in miR-146a high patients vs. 4.8 weeks in miR-146a low patients, P<0.05). miR-146a is therefore a strong candidate prognostic biomarker in NSCLC. Thus inducing miR-146a might be a therapeutic strategy for NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
miRBase: tools for microRNA genomics
Griffiths-Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm952 · Cited by 4,382
Brocken, P., van der Heijden, H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus-Oei, L.-F. (2014) · Respiration · doi:10.1159/000347096 · Cited by 4,002
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Pfister, D. G., Johnson, D. H., Azzoli, C. G., Sause, W., Smith, T. J., Baker Jr, S., Olak, J., Stover, D., Strawn, J. R., Turrisi, A. T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.053 · Cited by 1,413
The role of microRNA genes in papillary thyroid carcinoma
He, H., Jazdzewski, K., Li, W., Liyanarachchi, S., Nagy, R., Volinia, S., Calin, G. A., Liu, C.-G., Franssila, K., Suster, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509603102 · Cited by 1,215
Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses
Lu, L.-F., Boldin, M. P., Chaudhry, A., Lin, L.-L., Taganov, K. D., Hanada, T., Yoshimura, A., Baltimore, D., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.08.012 · Cited by 849
Wang, X., Tang, S., Le, S.-Y., Lu, R., Rader, J. S., Meyers, C., & Zheng, Z.-M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002557 · Cited by 741
Bhaumik, D., Scott, G. K., Schokrpur, S., Patil, C. K., Campisi, J., & Benz, C. C. (2008) · Oncogene · doi:10.1038/onc.2008.171 · Cited by 622
Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
Starczynowski, D. T., Kuchenbauer, F., Argiropoulos, B., Sung, S., Morin, R., Muranyi, A., Hirst, M., Hogge, D., Marra, M., Wells, R. A., et al. (2010) · Nature Medicine · doi:10.1038/nm.2054 · Cited by 577
Sos, M. L., Koker, M., Weir, B. A., Heynck, S., Rabinovsky, R., Zander, T., Seeger, J. M., Weiss, J., Fischer, F., Frommolt, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4055 · Cited by 504 · cited 1×
“H1650 cells have also a deletion of the 39 part of exon 8 and the entire exon 9 of PTEN, which causes loss of the protein [38].”
BackgroundmiR-146a Suppresses Invasion of Pancreatic Cancer Cells
Li, Y., VandenBoom, T. G., Wang, Z., Kong, D., Ali, S., Philip, P. A., & Sarkar, F. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2792 · Cited by 421
Hurst, D. R., Edmonds, M. D., Scott, G. K., Benz, C. C., Vaidya, K. S., & Welch, D. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3559 · Cited by 411
Loss of mir-146a function in hormone-refractory prostate cancer
Lin, S.-L., Chiang, A., Chang, D., & Ying, S.-Y. (2008) · RNA · doi:10.1261/rna.874808 · Cited by 382
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
Hummel, R., Hussey, D. J., & Haier, J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.027 · Cited by 344
Cui, J. G., Li, Y. Y., Zhao, Y., Bhattacharjee, S., & Lukiw, W. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178848 · Cited by 274 · cited 1×
“Because miR-146a was reported to also regulate the expression of IRAK-1, which can activate NF-kB signaling [13,34,35], we investigated the effects of miR-146a on NF-kB signaling pathways in the NSCLC cell lines.”
BackgroundShimamura, T., Lowell, A. M., Engelman, J. A., & Shapiro, G. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0933 · Cited by 259
MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor Progression
Scapoli, L., Palmieri, A., Muzio, L. L., Pezzetti, F., Rubini, C., Girardi, A., Farinella, F., Mazzotta, M., & Carinci, F. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300427 · Cited by 234
Biology of Interactions: Antiepidermal Growth Factor Receptor Agents
Harari, P. M., Allen, G. W., & Bonner, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8984 · Cited by 214
EGFR-mutated lung cancer: a paradigm of molecular oncology
Zhang, Z., Stiegler, A. L., Boggon, T. J., Kobayashi, S., & Halmos, B. (2010) · Oncotarget · doi:10.18632/oncotarget.186 · Cited by 197
Clinical Significance of miR-146a in Gastric Cancer Cases
Kogo, R., Mimori, K., Tanaka, F., Komune, S., & Mori, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2866 · Cited by 196
Paik, J. H., Jang, J.-Y., Jeon, Y. K., Kim, W. Y., Kim, T. M., Heo, D. S., & Kim, C.-W. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0494 · Cited by 173
MicroRNA Biogenesis and Cancer
Winter, J. J., & Diederichs, S. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-863-8_1 · Cited by 141
Chen, G., Kronenberger, P., Teugels, E., Umelo, I. A., & Grève, J. D. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-28 · Cited by 138
Self-citationSethi, G., Ahn, K. S., Chaturvedi, M., & Aggarwal, B. B. (2007) · Oncogene · doi:10.1038/sj.onc.1210544 · Cited by 124
Boominathan, L. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9257-9 · Cited by 120
MicroRNAs: regulators of oncogenesis and stemness
Papagiannakopoulos, T. Y., & Kosik, K. S. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-15 · Cited by 114
Pichler, K., Schneider, G., & Grassmann, R. (2008) · Retrovirology · doi:10.1186/1742-4690-5-100 · Cited by 109
Vinci, S., Gelmini, S., Pratesi, N., Conti, S., Malentacchi, F., Simi, L., Pazzagli, M., & Orlando, C. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.708 · Cited by 102
Nuclear Factor-κB Contributes to Anaplastic Thyroid Carcinomas through Up-Regulation of miR-146a
Pacifico, F., Crescenzi, E., Mellone, S., Iannetti, A., Porrino, N., Liguoro, D., Moscato, F., Grieco, M., Formisano, S., & Leonardi, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1128 · Cited by 101
MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis
Hou, Z., Xie, L., Yu, L., Qian, X., & Liu, B. (2011) · Medical Oncology · doi:10.1007/s12032-011-9862-7 · Cited by 85
Larner-Svensson, H., Williams, A. E., Tsitsiou, E., Perry, M. M., Jiang, X., Chung, K. F., & Lindsay, M. A. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-68 · Cited by 80
Thu, K. L., Vucic, E. A., Chari, R., Zhang, W., Lockwood, W. W., English, J. C., Fu, R., Wang, P., Feng, Z., MacAulay, C. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033003 · Cited by 78
Koivusalo, R., Krausz, E., Helenius, H. Y. M., & Hietanen, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011189 · Cited by 71
Targeted therapies for advanced non-small-cell lung cancer: Current status and future implications
Custodio, A., Méndez, M., & Provencio, M. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.04.001 · Cited by 65
Chen, G., Kronenberger, P., Teugels, E., Umelo, I. A., & Grève, J. D. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.070 · Cited by 44
Self-citationZero interaction response surfaces for combined-action assessment
Sühnel, J. (1996) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(97)00087-2 · Cited by 19
Closing in on the pathogenesis of the 5q- syndrome
Post, S. M., & Quintás‐Cardama, A. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.44 · Cited by 7
Cited by
Progress in corneal wound healing
Ljubimov, A. V., & Saghizadeh, M. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.07.002 · Cited by 872
Metadata
- Authors
- Chen, G., Umelo, I. A., Lv, S., Teugels, E., Fostier, K., Kronenberger, P., Dewaele, A., Sadones, J., Geers, C., & De Grève, J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-26
- Volume
- 8
- Issue
- 3
- Pages
- e60317
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2072378401
- Cited by
- 264
- References
- 40
- FWCI
- 10.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.